TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs.
Cell Death Dis. 2023 Jan 27;14(1):64. doi: 10.1038/s41419-022-05537-7.
Cell Death Dis. 2023.
PMID: 36707511
Free PMC article.